These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 27194200

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.
    Peacock A, Degenhardt L, Larance B, Cama E, Lintzeris N, Ali R, Bruno R.
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1321-33. PubMed ID: 26419615
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.
    Cassidy TA, Thorley E, Black RA, DeVeaugh-Geiss A, Butler SF, Coplan P.
    J Opioid Manag; 2017 Dec; 13(6):425-440. PubMed ID: 29308589
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin).
    Chilcoat HD, Coplan PM, Harikrishnan V, Alexander L.
    Drug Alcohol Depend; 2016 Aug 01; 165():221-8. PubMed ID: 27372220
    [Abstract] [Full Text] [Related]

  • 10. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
    Severtson SG, Ellis MS, Kurtz SP, Rosenblum A, Cicero TJ, Parrino MW, Gilbert MK, Buttram ME, Dasgupta N, BucherBartelson B, Green JL, Dart RC.
    Drug Alcohol Depend; 2016 Nov 01; 168():219-229. PubMed ID: 27716575
    [Abstract] [Full Text] [Related]

  • 11. Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates?
    Mullins ME, Hock K, Scott MG.
    Clin Toxicol (Phila); 2015 Jun 01; 53(5):493-4. PubMed ID: 25951899
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association Between Socio-Demographic and Health Functioning Variables Among Patients with Opioid Use Disorder Introduced by Prescription: A Prospective Cohort Study.
    Sanger N, Bhatt M, Shams I, Shahid H, Luo C, Tam SL, Samaan MC, de Souza R, Thabane L, Samaan Z.
    Pain Physician; 2018 Nov 01; 21(6):E623-E632. PubMed ID: 30508993
    [Abstract] [Full Text] [Related]

  • 14. The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers.
    Havens JR, Leukefeld CG, DeVeaugh-Geiss AM, Coplan P, Chilcoat HD.
    Drug Alcohol Depend; 2014 Jun 01; 139():9-17. PubMed ID: 24721614
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties.
    Gudin J, Levy-Cooperman N, Kopecky EA, Fleming AB.
    Pain Med; 2015 Nov 01; 16(11):2142-51. PubMed ID: 26108255
    [Abstract] [Full Text] [Related]

  • 19. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S, Sudarshan G, Manchikanti L.
    Pain Physician; 2014 Nov 01; 17(2):E119-28. PubMed ID: 24658483
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China.
    Yin W, Pang L, Cao X, McGoogan JM, Liu M, Zhang C, Li Z, Li J, Rou K.
    Addiction; 2015 Jan 01; 110 Suppl 1():51-60. PubMed ID: 25533864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.